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The heptapeptide, FTLDADF, identicai n sequence to the last seven amino acid residues of the carboxyl terminus of the R2 subunit of mouse 
ribonucleotide reductase (RR), and its NE-acetyl derivative both inhibit calf thymus RR. The Na-acetyl derivative is considerably more potent, 
displaying a K, of 20 PM. The same K, was found for N-AcFTLDADF inhibition of a reconstituted ribonucleotide reductase from calf thymus 
Rl and mouse R2, indicating that the C-termini of calf R2 and mouse R2 might be identical. Our results, taken together with previous results 
of others on inhibition of viral RR, suggest hat inhibition of RRs by peptides mimicking the C-terminus of R2 may be a general phenomenon. 
In addition, we have shown that an affinity column, FTLDADF-Sepharose 4B, can be used to prepare -95% pure calf thymus Ri, devoid of 
contamination with R2, in a very simple procedure that should be generally applicable to Rl pu~fi~tion from many sources. 
Ribonucleotide reductase; Peptide inhibition; Afhnity chromatography 
1. INTRODUCTION 2. EXPERIMENTAL 
Ribonucleotide diphosphate reductase (RR) is the en- 
zyme responsible for nucleoside reduction in 
Escherichia coli, eucaryotic organisms, and in viral par- 
ticles [l-3] and is thus a vital enzyme for DNA syn- 
thesis. RR activity depends upon the association of two 
unlike subunits, Rl and R2. Recently, a nonapeptide, 
YAGAVVDNL, corresponding to the C-terminus of 
the R2 subunit of herpes simplex virus RR (HSV RR) 
has been shown to inhibit enzymatic activity by com- 
peting with R2 for association with Rl [4-71. Extensive 
structure-function studies have shown that even modest 
changes in the parent peptide can lead to large 
decreases in inhibitory potency [8,9]. 
The C-terminal heptapeptide of R2 from mouse RR, 
FTLDADF, is identical or similar to that of other 
eucaryotic RRs (e.g. clam, yeast) but quite different 
from that of HSV RR [IO]. Here we demonstrate that 
the N”-acetyl derivative of this peptide is a potent in- 
hibitor of calf thymus RR and of the hybrid RR derived 
from the Rl subunit of calf thymus and the mouse R2 
subunit and that an affinity column, FTLDADF- 
Sepharose 4B, can be used to prepare RI that is nearly 
homogeneous and devoid of R2 content. 
A Beckman Protein-Synthesizer model 900 was used for the 
automated synthesis of FTLDADF by standard stepwise solid-phase 
Merrifield techniques. Ngf-Butyloxycarbonyl (Boc) protected amino 
acids were used throughout he synthesis. The N4 and side-chain pro- 
tected amino acids, Ngr-Boc-@-cyclohexyl-L-aspartic a id and Ngt- 
Boc-0-Bzl (be~yl)-L-~r~nine, were all in the L configuration. Pep- 
tide cleavage from the resin was achieved using the low-high HF pro- 
cedure [l 11. Peptide was solubilized by urea buffer sonication and 
purified by reverse-phase HPLC, using an ISCO chromatograph con- 
nected with a Hewlett-Packard Model 3390A integrator, on a Partisil 
10 ODS-3 Magnum 9 column (9.4 x 250 mm) with monitoring at 
214 nm. Solvent A: 0.1% TFA/H20; solvent B: 0.1% TFAKHpCN. 
Gradient: 5% Bto 40% B, O-40 min. The flow rate was 3 ml/min. 
Acetonitrile and water were HPLC grade solvent from Fisher Scien- 
tific. All other solvents and reagents were of analytical grade. 
Acetylation of FTLDADF by acetic anhydride to give NS 
acetylFTLDADF was performed in dimethylformamide prior to HF 
release of the peptide from the solid support [12]. ‘H NMR spectra, 
recorded on a Bruker AM-500 instrument, were consistent with the 
structure of both the parent peptide and the N*-acetyl derivative. 
High resolution mass spectra, recorded on a VG ZAB E ins~ment 
under FAB conditions, gave [M + HI+ molecular ions and fragmenta- 
tion patterns in agreement with the amino acid sequence and com- 
positions. The peptides were hydrolyzed for 22 h at 110°C with 6 N 
HCl giving the expected molar ratio of amino acids ( f 3%). 
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FTLDADF-Sepharose 4B was prepared by suspending activated 
CH-Sepharose 4B (1.0 g) in 5 ml of 1 mM HCI and washing with 
200 ml of 1 mM HCI in a Buchner funnel. After drying the gel briefly 
under suction the slightly moist cake was added with stirring to 5 ml 
of 0.1 M NaHCOp buffer (pH 8.4) containing 1.5 mg of the 
FTLDADF [13]. The reaction was allowed to proceed for 1 h at 4°C. 
Glycine (2 M, 5 ml) was then added to the reaction mixture at the 
same temperature to destroy the excess active groups on the gel [13] 
and stirring was continued for 40 min. The gel was then filtered, 
washed with 50 ml of 50 mM ‘Iris-Cl (pH 7.6) buffer, suspended in 
10 ml of distilled water and packed into a 1.5 x 8 cm column. Prior 
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to use the column was washed with 40 ml of 6 M guanidine 
hydrochloride and 20 ml of distilled water. It was stored at 4°C. 
Calf thymus RR was prepared either as described by Engstram et 
al. [14,15] and revised by Mattaliono [16] or in a new procedure in- 
volving the use of FTLDADF-Sepharose 4B. Briefly, the first pro- 
cedure involves homogenizing calf thymus, precipitating DNA from 
the supernatant by addition of streptomycin sulfate, ammonium 
sulfate fractionation, DEAE-cellulose (DE-52) chromatography of 
the 40% ammonium sulfate pellet, and a final chromatography on a 
dATP-Sepharose 4B column, prepared according to Berglund and 
Eckstein [17]. Calf thymus RR was eluted from this column by 
50 mM ATP, giving a preparation that was 70-80% Rl as judged by 
SDS-PAGE analysis (see below). In the second procedure, partially 
purified RR obtained by DE52 column chromatography as described 
above (about 50 ml, 15 mg protein/ml) was loaded in portions onto 
the FTLDADF-Sepharose 4B column described above, which had 
been pre-equilibrated with 20 ml of buffer A (50 mM Tris-Cl, 
0.1 mM DTT, pH 7.6) at room temperature. The column was then 
washed with buffer A (50 ml) and buffer A containing 0.1 M KC1 
(100 ml) until no further protein eluted. Rl was eluted with buffer A 
containing 0.5 M KC1 (10 ml). Both procedures yielded about 1 mg 
of purified Rl from 1.5 kg of calf thymus. 
thymus RR proceeds, the ratio of R2/Rl decreases, as 
does the yield of recovered enzymatic activity [14,15]. 
Accordingly, in the work reported here we used the 
relatively crude DE-52 eluate as the source of calf 
thymus RR, and the much purer dATP-Sepharose 4B 
eluate in combination with crude mouse extract, as the 
source of the hybrid calf thymus : mouse RR, following 
McCarty et al. [18]. The specific activities of crude 
DE-52 eluate and of dATP-Sepharose 4B eluate were 
typically 4.5 U/mg protein and 27 U/mg protein, 
respectively. Combination of 7 pg of dATP-Sepharose 
4B eluate with 7.5 pg of crude mouse cell extract pro- 
tein, gave a specific activity of 520 U/mg of purified 
calf thymus RR. The activity of the crude mouse ex- 
tract in the absence of calf thymus RR was very low. 
Crude mouse RR was prepared from the SC2 mouse cell line deriv- 
ed from hydroxyurea-resistant mouse L cells, obtained as a gift from 
Dr J.A. Wright, essentially as described by McClarty et al. [18]. 
Briefly, the cells were grown in 100 mm culture dishes containing 
Dulbecco’s modified Eagle medium (D-MEM) plus 10% fetal calf 
serum, 1% 2 mM glutamine, and 1% penicillin-streptomycin the 
absence of hydroxyurea. Hydroxyurea (5 mM) was added 3 days 
before harvesting. The cells were removed from the plates by tryp- 
sinization and washed with ice-cold phosphate-buffered saline (PBS), 
pH 7.5, three times and the pellet was resuspended in 50 mM 
potassium phosphate buffer, pH 7.6, containing 2 mM MgC12, 1 mM 
dithiothreitol (DTT), and 1 mM PMSF to a density of about 2.5 x 
10’ cells per ml. The cells were disrupted by sonication and the 
suspension was cleared from cell debris by centrifugation at 15 000 x 
g for 15 min at 4°C. The resulting cell extract was 1.5 mg/ml in pro- 
tein and kept frozen at -70°C. Approximately 13.5 ml of crude ex- 
tract was obtained from cells grown in seventy 100 mm culture 
dishes. 
Both the heptapeptide FTLDADF and its N”-acetyl 
derivative inhibit calf thymus RR (Fig. 1). The ap- 
parent Ki for the acetyl derivative (20 ,uM) is approx- 
imately 10 times lower than that for the underivatized 
peptide. This Ki value corresponds quite closely to that 
measured by Gaudreau et al. [8,9] for inhibition of 
HSV-RR by the N”-acetyl derivative of 
YAGAVVNDL, the nonapeptide that corresponds to 
the C-terminus of HSV-R2 (the Ki for the correspon- 
ding underivatized nonapeptide is 3 times higher), 
leading to the suggestion that inhibition of RRs by the 
peptides mimicking the C-terminus of R2 may be a 
general phenomenon. 
RR activities were assayed at 35°C following the method of Steeper 
and Steuart [ 191. The reaction mixture, made up in a final volume of 
100~1 of 60 mM Hepes, pH 7.6 buffer, contained 2.7 mM 
Mg(OAc)z, 8.75 mM NaF, 0.05 mM FeCl3, 25 mM DTT, 4 mM 
ATP, 0.1 mM [5-‘H]CDP (12 Ci/mol), 2 mM phenylmethane 
sulfonyl fluoride, RR, and varying amounts of peptide inhibitor. 
Peptide concentrations in stock solutions were determined spec- 
trophotometrically, exploiting the electronic absorption of the phenyl 
side chains. In all assays inhibitors were added prior to enzyme. One 
RR unit is defined as the amount of enzyme generating 1 nmol of 
dCDP/h under standard conditions. 
The apparent Ki for inhibition of hybrid calf 
thymus : mouse RR by N”-acetylFTLDADF, which is a 
measure of the ability of the peptide derivative to com- 
pete with R2 binding to RI, is exactly the same as that 
for inhibition of the calf thymus enzyme (Fig. 1). Since 
Gaudreau et al. have shown that even small changes in 
the structure of the nonapeptide YAGAVVNDL can 
drastically reduce the potency of the resulting peptide 
as an HSV-RR inhibitor, our results suggest that the C- 
termini of calf thymus and mouse R2 are either iden- 
tical or very similar. Viewed from a different vantage 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was per- 
formed using 12% acrylamide as described by Laemmli [20]. Western 
blots were performed as described [21], using monoclonal antibody 
AC1 to Rl obtained from In Ro BioMedTek (LJme&, Sweden). Pro- 
tein amount was determined according to Bradford [22]. 
(5-3H]CDP was purchased from Amersham. CDP, ATP, dCDP, 
DE52, and Sepharose-CL-4B were from Sigma. CH-Sepharose 4B 
was from Pharmacia P-L Biochemicals. Dowex-l-Chloride was from 
Aldrich. Protein molecular weight standards were from Biorad. 
3. RESULTS AND DISCUSSION 
1 
OO 50 100 1.50 200 
RR in crude extracts of calf thymus, though deficient 
in R2, retains enough of this subunit to permit 
measurement of enzymatic activity [ 14,151. In contrast, 
the extract of hydroxyurea-resistant mouse cells has an 
excess of R2 over Rl [18]. As purification of calf 
Concentration of Inhibitor (NM ) 
Fig. 1. Inhibition of calf thymus RR activity by FTLDADF (O--O) 
and by NgacetylFTLDADF ( M) and of hybrid calf thymus- 
mouse RR activity by N”-acetylFTLDADF (ti). 1 .O-1.5 U of 
RR activity was used in the assays. 
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point, the results of Gaudreau et al. [8,9] and ourselves 
suggest that even small differences in such C-terminal 
sequences could be exploited in designing peptide in- 
hibitors having pronounced specificities as inhibitors of 
RRs from different species. Efforts in this direction are 
underway. 
The high activity of NgacetylFTLDADF as an in- 
hibitor of RR activity suggested that FTLDADF could 
be used as an affinity chromatography ligand for the 
purification of Rl. Accordingly, an FTLDADF- 
Sepharose 4B column was prepared as described in sec- 
tion 2, the crude DE-52 eluate was applied, and, 
following extensive washing at low salt, Rl was eluted 
at high salt. It is important to emphasize that 
prewashing of the column with 6 M guanidine 
hydrochloride was essential for its proper functioning. 
The crude DE52 eluate, the low and high salt washes 
of the FTLDADF-Sepharose 4B, and Rl prepared by 
1 2 3 4 5 6 
97.4 
66.2 
42.7 
31.0 
21.5 
14.4 
Fig. 2. SDS-PAGE analysis of RR preparations. Top: Coomassie 
blue staining. Bottom: Western blot. (Lanes 1 and 6) Protein 
molecular weight standards; 97.4 K, phosphorylase b; 66.2 K, bovine 
serum albumin;42.7 K, ovalbumin; 31.0 K, carbonic anhydrase; 
21.5 K, soybean trypsin inhibitor; 14.4 K, lysozyme; (lane 2) DE52 
eluate, 5 /g protein; (lane 3) buffer A eluate of FTLDADF- 
Sepharose 4B, 5 gg protein; (lane 4) 0.5 M KC1 wash of FTLDADF- 
Sepharose 4B, 5 yg protein; (lane 5) Rl purified on dATP-Sepharose 
4B, 5 pg protein. 
dATP-Sepharose 4B chromatography were analyzed by 
SDS-PAGE, as shown in Fig. 2. From the Western blot 
results it is apparent that virtually all of the Rl 
(molecular mass 85 kDa [14,15]) in the crude DE52 
eluate is retained on the FTLDADF-Sepharose 4B col- 
umn, so that this step results in a 750-fold purification 
with near quantitative yield. From the Coomassie blue 
staining it is clear that chromatography of the crude 
DE52 eluate on FTLDADF-Sepharose 4B yields a 
somewhat purer protein (we estimate -95%) than 
chromatography on dATP-Sepharose 4B. Consistent 
with this result is the finding that FTLDADF- 
Sepharose 4B-purified Rl had essentially no RR activi- 
ty when assayed alone (it did, however, have a specific 
activity of 700 U/mg Rl when assayed in combination 
with 7.5 pg of crude mouse cell extract protein) 
whereas, as described above, dATP-Sepharose 4B- 
purified RI retained RR activity, indicating the 
presence of contaminating R2. From these results, we 
consider FTLDADF-Sepharose 4B chromatography to 
be the method of choice for the preparation of Rl. Fur- 
thermore, given the apparent generality of R2 C- 
terminal peptide inhibition of RR activity, it appears 
likely that analogous columns, prepared from the ap- 
propriate R2 C-terminal sequence, will be suitable for 
the purification of Rl subunits from a large variety of 
cells. 
Acknowledgement: This work was supported by a grant to B.S.C. 
and H.R. from Sterling Drug Inc., Malvern, PA. R.A.S. and R.H. 
gratefully acknowledge a grant from Bachem, Inc., Torrance, CA. 
REFERENCES 
111 
121 
131 
141 
151 
WI 
171 
PI 
PI 
1101 
r111 
1121 
v31 
Reichard, P. and Ehrenberg, A. (1983) Science 221, 514-519. 
Averett, D.R., Lubbers, C., Elion, G.B. and Spector, T. (1983) 
J. Biol. Chem. 258, 9831-9838. 
Ashley, G.W. and Stubbe, J. (1985) Pharmacol. Ther. 30, 
301-329. 
Dutia, B.M., Frame, M.C., Subak-Sharpe, J.H., Clark, W.N. 
and Marsden, H.W. (1986) Nature 321, 439-441. 
Cohen, E.A., Gaudreau, P., Brazeau, P. and Langelier, Y. 
(1986) Nature 321, 441-443. 
McClements, W., Yamanaka, G., Garsky, V., Perry, H., 
Bacchetti, S., Colonno, R. and Stein, B.R. (1988) Virology 162, 
270-273. 
Paradis, H., Gaudreau, P., Brazeau, P. and Langelier, Y. 
(1988) J. Biol. Chem. 263, 16045-16050. 
Gaudreau, P., Michaud, J., Cohen, E.A., Langelier, Y. and 
Brazeau, P. (1987) J. Biol. Chem. 262, 12413-12416. 
Gaudreau, P., Paradis, H., Langelier, Y. and Brazeau, P. 
(1990) J. Med. Chem. 33. 723-730. 
Ellidge, S.J. and Davis; R.W. (1987) Mol. Cell Biol. 7, 
2783-2793. 
Stewart, J.M. and Young, J.D. (1984) Solid Phase Peptide 
Synthesis, 2nd edn, pp. 84-92, Pierce Chemical Co., Rockford, 
IL. 
Bayer, E., Eckstein, H., Hagele, K., Kiinig, W.A., Briining, 
W., Hagenmaier, H. and Parr, W. (1970) J. Am. Chem. Sot. 
92, 1735-1738. 
Cuatrecasas, P. and Parikh, I. (1972) Biochemistry 11, 
2291-2297. 
63 
Volume 272, number 1,2 FEBS LETTERS October 1990 
[14] Engstriim, Y., Eriksson, S., Thelander, L. and Akerman, M. 
(1979) Biochemistry 18, 2941-2948. 
1151 Thelander, L., Eriksson, S. and Akerman, M. (1980) J. BioI. 
Chem. 255,742&743X 
f16] Mat~~aoo, R.F. (1982) PhD Thesis, University of New 
Hampshire. 
1171 Berglund, 0. and Eckstein, F. (1972) Eur. J. Biochem. 28, 
492-496. 
[19] Steeper, J.R. and Steuart, CD. (1970) Anal. Biochem. 34, 
123-130. 
[ZO] LaemmIi, U.K. (1970) Nature 227, 680-685. 
fZl] Rubin, H., Wang, Z.M., Nickbarg, E.B., McLarney, S., 
Naidoo, N., Scboenberger, U.L., Johnson, 3.L. and 
Cooperman, B.S. (1990) J. Biol. Chem. 265, 1199-1207. 
[22] Bradford, M. (1976) Anal. Biochem. 72, 248-254. 
[18] McClarty, GA., Ghan, A.K.M. and Wright, J.A. (1986) 
Somat. Cell Mol. Gene& 12, 12I-131. 
64 
